Consistently, the pancreatic β cell-specific knockout of Mfn1/2 in mice (βMfn1/2 KO) led to several metabolic abnormalities, such as glucose intolerance, impaired glucose clearance, and a decrease in plasma insulin levels. Here, MFN1 is linked to Glucose intolerance.